Human immunodeficiency virus and solid organ transplantation: a 15-year retrospective audit at a tertiary Australian transplant centre.

2021-06

Griffin, David W J

Kotecha, Sakhee

Basu, Gopal

Gow, Paul J

Lau, Jillian S Y

Morrissey, Catherine O

Hoy, Jennifer F

antiretroviral therapy

chronic kidney disease

chronic liver disease

chronic lung disease

human immunodeficiency virus

solid organ transplantation

Journal Article

0000-0001-9249-1780

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

10.1111/imj.15423

The incidence of end-stage organ disease in people living with human immunodeficiency virus (HIV) (PLWH) is increasing, as people live longer due to potent, tolerable antiretroviral therapy (ART). Consequently, the number of PLWH who would benefit from solid organ transplant (SOT) is rising. The SOT experience in PLWH in Australia remains limited. Aim To retrospectively review the outcomes for SOT in PLWH at our service, in Victoria, Australia.

link

Internal Medicine Journal 2022

Internal Medicine Journal

1445-5994